News: Science & Tech
All News Stories
News Releases
UofL receives $11.5 million to advance cancer immunotherapies
September 14, 2020
Cancer remains one of the most difficult and deadly challenges in human health, affecting Kentuckians at a higher rate than residents of any other state and killing more than 600,000 people each year in the U.S. alone.
UofL-born cell therapy for organ transplants enters Phase 3 trial
August 27, 2020
A cell therapy born at the University of Louisville that could improve the lives of kidney transplant recipients has entered its Phase 3 clinical trial — the last step before applying for FDA approval.
UofL immunologist summarizes functions of protein family associated with obesity
August 20, 2020
Fatty acid binding proteins (FABPs) serve as a type of chaperone, coordinating the transport of fatty acids and other molecules between cells.